Profound Medical (TSE:PRN) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts and uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Profound Medical Corp. has announced a $35 million public offering of its common shares, aimed at advancing the commercialization of its TULSA-PRO® and Sonalleve® systems. The offering is led by Raymond James Ltd. and Lake Street Capital Markets, with expected proceeds to support the company’s expansion efforts.
For further insights into TSE:PRN stock, check out TipRanks’ Stock Analysis page.
